Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

News Conference News TCT 2018

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

L.A. McKeown

September 27, 2018

Presentation TCT Abstracts Posters 2018

Successful Rescue of a Mal-Deployed Transcatheter Pulmonic Valve

Presenter: Taishi Hirai

September 25, 2018

Presentation TCT 2018

Transcatheter Carotid Body Denervation (Cibiem): Extended Follow-Up and Future Directions

Presenter: Mark C. Bates, Farrell O. Mendelsohn, Felix Mahfoud

September 24, 2018

News Daily News

Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows

Michael O'Riordan

September 12, 2018

News Conference News ESC 2018

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Shelley Wood

August 20, 2018

News Daily News

Late Conduction Defects After TAVR: Finding ‘Sweet Spot’ for Early Discharge

Michael O'Riordan

August 08, 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2018

Shelley Wood

July 02, 2018

News Conference News The Structural Heart Disease Summit 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

News Conference News The Structural Heart Disease Summit 2018

Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year

Michael O'Riordan

June 21, 2018

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2018

Shelley Wood

April 02, 2018

News Daily News

Fewer Complications, Lower Risk of Death With Conscious Sedation for TAVR

Michael O'Riordan

March 27, 2018

News Conference News ACC 2018

ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins

Shelley Wood

March 10, 2018

News Conference News CRT 2018

Ticagrelor: Better Platelet Blockade Post-TAVR?

Michael O'Riordan

March 07, 2018

News Conference News CRT 2018

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Michael O'Riordan

March 05, 2018

News Daily News

Edwards Voluntarily Recalls Cardioband ‘Anchors’ Used in Mitral and Tricuspid Repair

Michael O'Riordan

February 27, 2018

News Daily News

Surprising Rate of Cardiac Amyloidosis in TAVR Patients Poses Tough Questions for Diagnosis, Decision-Making

Michael O'Riordan

February 01, 2018

News Daily News

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Michael O'Riordan

January 26, 2018

News Daily News

One-Third of TAVR and SAVR Patients Are Depressed, Upping Mortality Risk

L.A. McKeown

January 18, 2018

Advertisement

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

Successful Rescue of a Mal-Deployed Transcatheter Pulmonic Valve

Transcatheter Carotid Body Denervation (Cibiem): Extended Follow-Up and Future Directions

Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Late Conduction Defects After TAVR: Finding ‘Sweet Spot’ for Early Discharge

TCTMD’s Top 10 Most Popular Stories for June 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

TCTMD’s Top 10 Most Popular Stories for March 2018

Fewer Complications, Lower Risk of Death With Conscious Sedation for TAVR

ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins

Ticagrelor: Better Platelet Blockade Post-TAVR?

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Edwards Voluntarily Recalls Cardioband ‘Anchors’ Used in Mitral and Tricuspid Repair

Surprising Rate of Cardiac Amyloidosis in TAVR Patients Poses Tough Questions for Diagnosis, Decision-Making

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

One-Third of TAVR and SAVR Patients Are Depressed, Upping Mortality Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content